Order Article Reprints

Bagán A, Rodriguez-Arévalo S, Taboada-Jara T, Griñán-Ferré C, Pallàs M, Brocos-Mosquera I, Callado LF, Morales-García JA, Pérez B, Diaz C, et al. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics. 2023; 15(10):2381. https://doi.org/10.3390/pharmaceutics15102381

Bagán, Andrea, Sergio Rodriguez-Arévalo, Teresa Taboada-Jara, Christian Griñán-Ferré, Mercè Pallàs, Iria Brocos-Mosquera, Luis F. Callado, José A. Morales-García, Belén Pérez, Caridad Diaz, and et al. 2023. "Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease" Pharmaceutics 15, no. 10: 2381. https://doi.org/10.3390/pharmaceutics15102381

Bagán, A., Rodriguez-Arévalo, S., Taboada-Jara, T., Griñán-Ferré, C., Pallàs, M., Brocos-Mosquera, I., Callado, L. F., Morales-García, J. A., Pérez, B., Diaz, C., Fernández-Godino, R., Genilloud, O., Beljkas, M., Oljacic, S., Nikolic, K., & Escolano, C. (2023). Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease. Pharmaceutics, 15(10), 2381. https://doi.org/10.3390/pharmaceutics15102381